Erik Doevendans has over​ 20 years’ industry experience in CMC and a background in quality assurance, medicinal assessments, regulatory affairs and manufacturing operations. He started his own consultancy in 2007 and joined CNS Biodesk as a principal consultant in 2015. Notably Erik was previously a pharmaceutical assessor at the Dutch Medicines Board and an expert to the EMA. 

Erik obtained a MSc in Pharmacy at Utrecht University, where he is still involved in the department of Pharmaceutics, with special interest in biosimilars and the relevancy of animal models used in non-clinical development.

LinkedIn Profile